Search Results - Jonathan H. Shepherd

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression

    The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression by Jonathan H. Shepherd, Iván P. Uray, Abhijit Mazumdar, Anna Tsimelzon, Michelle I. Savage, Susan G. Hilsenbeck, Powel H. Brown

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells

    Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells by Patrick D. Rädler, Barbara L. Wehde, Aleata A. Triplett, Hridaya Shrestha, Jonathan H. Shepherd, Adam D. Pfefferle, Hallgeir Rui, Robert D. Cardiff, Charles M. Perou, Kay‐Uwe Wagner

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival

    Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival by Petra den Hollander, Kathryn Rawls, Anna Tsimelzon, Jonathan H. Shepherd, Abhijit Mazumdar, Jamal Hill, Suzanne A.W. Fuqua, Jenny C. Chang, C. Kent Osborne, Susan G. Hilsenbeck, Gordon B. Mills, Powel H. Brown

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma

    Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma by Binita Chakraborty, Jovita Byemerwa, Jonathan H. Shepherd, Corinne Haines, Robert Baldi, Weida Gong, Wen Liu, Debarati Mukherjee, Sandeep Artham, Felicia Lim, Yeeun Bae, Olivia Brueckner, Kendall Tavares, Suzanne E. Wardell, Brent A. Hanks, Charles M. Perou, Ching‐yi Chang, Donald P. McDonnell

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer

    Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Can... by Aranzazu Fernández-Martínez, Ian E. Krop, David W. Hillman, Mei‐Yin C. Polley, Joel S. Parker, Lucas J. Huebner, Katherine A. Hoadley, Jonathan H. Shepherd, Sara M. Tolaney, N. Lynn Henry, Chau T. Dang, Lyndsay N. Harris, Donald A. Berry, Olwen Hahn, Clifford A. Hudis, Eric P. Winer, Ann H. Partridge, Charles M. Perou, Lisa A. Carey

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer

    Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer by Erika J. Crosby, Chaitanya R. Acharya, Anthony-Fayez Haddad, Christopher A. Rabiola, Gangjun Lei, Jun-Ping Wei, Xiaoyi Yang, Tao Wang, Cong-Xiao Liu, Kay‐Uwe Wagner, William J. Muller, Lewis A. Chodosh, Gloria Broadwater, Terry Hyslop, Jonathan H. Shepherd, Daniel P. Hollern, Xiaping He, Charles M. Perou, Shengjie Chai, Benjamin K. Ashby, Benjamin G. Vincent, Joshua C. Snyder, Jeremy Force, Michael A. Morse, H. Kim Lyerly, Zachary C. Hartman

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer

    CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Nega... by Jonathan H. Shepherd, Karla V. Ballman, Mei‐Yin C. Polley, Jordan D. Campbell, Huihui Fan, Sara R. Selitsky, Aranzazu Fernández-Martínez, Joel S. Parker, Katherine A. Hoadley, Zhiyuan Hu, Yan Li, Matthew G. Soloway, Patricia A. Spears, Baljit Singh, Sara M. Tolaney, George Somlo, Elisa R. Port, X. Cynthia, Charles Kuzma, Eleftherios P. Mamounas, Mehra Golshan, Jennifer R. Bellon, Deborah Collyar, Olwen Hahn, Clifford A. Hudis, Eric P. Winer, Ann H. Partridge, Terry Hyslop, Lisa A. Carey, Charles M. Perou, William M. Sikov

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: